Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3

Molecular and Cellular Biology

Volumn 20, Issue 17, 2000, Pages 6483-6495

  Mannhardt, B ^a   Weinzimer, S A ^a   Wagner, M ^a   Fiedler, M ^a   Cohen, P ^a   Jansen Durr, P ^a   Zwerschke, W ^a  

^a TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH INHIBITOR; ONCOPROTEIN; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 3;

APOPTOSIS; ARTICLE; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VIRUS GENE; WART VIRUS;

APOPTOSIS; BLOTTING, NORTHERN; CELL DIVISION; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE TRANSFERASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PRECIPITIN TESTS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0033838263     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.17.6483-6495.2000     Document Type: Article

References (94)

1. Human papillomaviruses and associated malignancies
2. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
3. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells
4. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors
5. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex
6. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells
7. The region of the HPV E7 oncoprotein homologous to adenovirus E1A and SV40 large T antigen contains separate domains for RB binding and casein kinase 2 phosphorylation
8. The IGF-I receptor and cancer
9. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins
10. Insulin-like growth factor binding proteins (IGFBPs): Physiological and clinical implications
11. The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53
12. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway
13. Retinoblastoma protein recruits histone deacetylase to repress transcription
14. Induction of the growth inhibitor IGF-binding protein 3 by p53
15. The IGF axis and programmed cell death
16. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
17. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
18. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
19. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts
20. p53 Functions as a cell cycle control protein in osteosarcomas
21. Genetic changes associated with immortalization. A review
22. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interactions with the same set of cellular proteins
23. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
24. A point mutational analysis of human papillomavirus type 16 E7 protein
25. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1
26. WAF1, a potential mediator of p53 tumor suppression
27. Inhibition of cdk activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
28. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer ceils to programmed cell death in a non-IGF-dependent manner
29. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts
30. Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: Attenuation of the mitogenic response to IGF-I
31. Cdi1, a human Gl-phase and S-phase protein phosphatase that associates with Cdk2
32. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: A prognostic study
33. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence
34. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
35. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial ceils and thereby potentiates the effects of insulin-like growth factor 1
36. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
37. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
38. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53
39. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha
40. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes
41. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21CIP1-mediated inhibition of cdk2
42. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
43. Two immunodominant regions of the human papillomavirus type 16 E7 protein are masked in the nuclei of monkey COS-1 cells
44. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor
45. The E6 and E7 genes of human papilloma virus-type 16 protect primary astrocyte cultures from injury
46. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
47. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells
48. DNA tumour viruses oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1
49. Retinoblastoma-protein-dependent cell-cycle inhibition by the turnout suppressor p16
50. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins
51. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
52. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity
53. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107
54. Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts
55. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
56. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
57. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
58. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells
59. TGF-β-induced ceil growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
60. Cell cycle regulation by the ubiquitin pathway
61. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development
62. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development
63. Genetic analysis of indefinite division in human cells: Identification of four complementation groups
64. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA binding protein, TBP
65. Apoptosis in human papillomavirus16 E7-, but not E6immortalized human uroepithelial cells
66. Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism
67. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
68. Antiproliferative action of tumor necrosis factor-a on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation
69. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes
70. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
71. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
72. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts
73. The INK4A/ARF locus and its two gene products
74. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein
75. Origins of G(1) arrest in enescent human fibroblasts
76. The E7 protein of human papillomavirus s type 16 sensitizes primary human keratinocytes to apoptosis
77. Increase in expression level of p21(sdi1/cip1/waf1) with increasing division age in both normal and SV40-transformed human fibroblasts
78. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A
79. Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle
80. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7
81. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
82. Regulation of the cell cycle by viral oncoproteins
83. Mutational analysis of human papillomavirus type 16 E7 functions
84. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7
85. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein
86. Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes
87. Overcoming cellular senescence in human cancer pathogenesis
88. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein
89. Human papillomaviruses in the pathogenesis of anogenital cancer
90. Cell transformation by the E7 oncoprotein of HPV type 16: Interactions with nuclear and cytoplasmic target proteins
91. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein
92. Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein
93. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein